CDKN1A and prostate cancer: Thrombin inhibits DU145 prostate cancer cell, MEF murine fibroblast cell and CHRF human megakaryocyte cell growth via up-regulation of p21 and capases via a p53 independent and STAT1 dependent pathway [32].